In this study, we investigated the effect of RBMS3 expression on prognosis and tumor angiogenesis in GC and found RBMS3− GC patients were significantly related to poorer prognosis and higher tumor angiogenesis compared with RBMS3+ GC patients, which was consistent with the previous studies [9, 10, 12]. Here, RBMS3 is linked to gastric cancer.